Home > Products > Animal Tumor Cell Lines >
LL/2(LLc1) | ||||
|---|---|---|---|---|
| Product Name | LL/2(LLc1) | |||
| Price | Get Quote | |||
| Product Code | LL/2 (LLc1); LL/2; LL2; LLC1; LLC; Lewis lung carcinoma line 1; Lewis lung carcinoma; Lewis Lung Cancer; Lewis-Lung; Lewis Lung | |||
| Cat.No | ABC-TC0591 | Species | Mouse | |
| Size/Quantity | 1 vial | Biosafety Level | 1 | |
| Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
| Description | The Lewis lung carcinoma line 1 (LLC1), also known as LL-2, was the lung cancer cell line derived from a primary Lewis lung carcinoma tumor in a C57BL mouse. This cell line is tumorigenic and compatible with the murine immune system. It retains its tumorigenicity in C57B1 mice,
Why choose LL-2(LLC1) from AcceGen? LL-2 cells from AcceGen undergo rigorous quality control measures to ensure sterility and exclude mycoplasma contamination using PCR and luminescence-based assays. Bacterial or fungal contaminations are detected through daily visual cell monitoring. Production involves professional operators who adhere to optimal standards, ensuring the reliability and integrity of LL-2 cells. | |||
| Disease | Lung Cancer | |||
| Source Organ | Lung | |||
| Recommended Medium And Supplement | DMEM + 10% HS | |||
| Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
| Application | FOR RESEARCH USE ONLY LL-2(LLC1) cells have diverse applications in cancer research. They are useful in focus assays to evaluate drug-induced cytotoxicity, providing insights into the effects of various compounds on cancer cell viability. Additionally, LL-2(LLC1) cells are commonly employed in syngeneic animal models to assess the efficacy of anticancer treatments in vivo. These models enable researchers to study treatment effectiveness and potential side effects in a controlled environment. Furthermore, LL-2(LLC1) cells are valuable in identifying key factors in human cancer. Researchers can evaluate the impact of antibodies or inhibitors on LL-2(LLC1) cells, shedding light on potential therapeutic targets and aiding in the development of targeted cancer therapies. Overall, LL-2(LLC1) cells serve as valuable tools for investigating drug cytotoxicity, treatment efficacy, and identifying key factors in cancer biology. | |||
| Growth Conditions | 37 ℃, 5% CO2 | |||
| Growth Mode | Adherent and Suspension | |||
| Product Type | Mouse Lung Cancer Cell Lines | |||
| Product Image |  | |||
generating primary tumors and lung metastases identical to the original tumor. LL-2(LLC1) cells grow as a monolayer in RPMI 1640 medium supplemented with 2% fetal calf serum, with a plating efficiency of approximately 94% and a 21-hour doubling time. Reports also indicate their stable growth in DMEM with 10% FBS.- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
